top of page

Publications

January 5, 2018

Antimicrobial Agents and Chemotherapy

Development of Protective Immunity in New Zealand White Rabbits challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen

January 5, 2018

Antimicrobial Agents and Chemotherapy

Development of Protective Immunity in New Zealand White Rabbits challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen

January 5, 2017

Clinical and Translational Science

Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

January 5, 2017

Clinical and Translational Science

Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

October 5, 2016

Antimicrobial Agents and Chemotherapy

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

October 5, 2016

Antimicrobial Agents and Chemotherapy

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

July 20, 2016

Antimicrobial Agents and Chemotherapy

Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies

July 20, 2016

Antimicrobial Agents and Chemotherapy

Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies

bottom of page